摘要
白血病是脱离正常分化轨道具有克隆形成能力的细胞在时间和空间上应该凋亡而未发生凋亡，并呈现克隆性增殖和浸润其他脏器的一种恶性血液病。发生血液病主要有两个前提条件：一是白血病干细胞（LSC）的出现，二是患者免疫功能不能清除LSC和（或）不能控制其增殖。可见，导致白血病的根基便是LSC，
出处
《中华内科杂志》
CAS
CSCD
北大核心
2008年第6期515-517,共3页
Chinese Journal of Internal Medicine
参考文献11
-
1Florian S, Sonneck K, Hauswirth AW, et al. Detection of molecular targets on the surface of CD34 +/CD38 - stem cells in various myeloid malignancies. Leuk Lymphoma, 2006, 47:207- 222.
-
2Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature, 2003, 423 ( 6937 ) :255-260.
-
3Zheng X, Beissert T, Kukoc-Zivojnov N, et al. Gamma-catenin contributes to eukemogenesis induced by AML-associated translocation products by increasing the serf-renewal of very primitive progenitor cells. Blood, 2004, 103:3535-3543.
-
4Muller-Tidow C, Steffen B, Cauvet T, et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol, 2004, 24:2890- 2904.
-
5Krivtsov AV, Twomey D, Feng Z, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL- AF9. Nature ,2006,442:818-822.
-
6Levis M, Murphy KM, Pham R, et al. Internal tandem duplications of the FLT3 gene are present in leukemia stem cells. Blood, 2005,106:673-680.
-
7Stubbs MC, Kim YM, Krivtsov AV, et al. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Leukemia, 2008, 22:66- 77.
-
8Bardet V, Tamburini J, Ifrah N, et al. Single cell analysis of phosphoinositide 3-kinase/Akt and ERK activation in acute myeloid leukemia by flow cytometry. Haematologica, 2006, 91 : 757-764.
-
9Raaijmakers MH, de Grouw EP, Heuver LH, et al. Breast cancer resistance protein in drug resistance of primitive CD34 + 38 - ceils in acute myeloid leukemia. Clin Cancer Res, 2005, 11 : 2436- 2444.
-
10Guzman ML, Rossi RM, Kamischky L, et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood, 2005, 105:4163- 4169.
同被引文献4
-
1李春丽,赵娜,张王刚.白血病干细胞研究进展[J].临床血液学杂志,2007,20(4):252-255. 被引量：1
-
2范良生,陈刚,马丁.柯萨奇-腺病毒受体在肿瘤发生发展机制中的研究进展[J].癌症,2009,28(3):333-336. 被引量：8
-
3邹德生,张博,张兰杰,辛广,李桂英.人细胞周期蛋白D1在大肠杆菌中的可溶性表达与纯化[J].鞍山师范学院学报,2010,12(2):36-39. 被引量：1
-
4康颖,尹松梅.CD47生理功能的研究[J].中国实验血液学杂志,2003,11(4):437-440. 被引量：9
-
1王延群.诱发肝癌的危险因素知多少[J].健康生活,2013(7):32-33. 被引量：1
-
2程鑫,张仕状,王滨.胃窦癌伴幽门梗阻2例分析[J].潍坊医学院学报,2005,27(1):75-76.
-
3侯建章,侯振江,刘汝海.血清VEGF及其受体在消化道肿瘤预后中的研究进展[J].国际检验医学杂志,2013,34(6):699-701. 被引量：2
-
4李鹰飞,肖冰.肿瘤始动的根基-肿瘤干细胞[J].现代消化及介入诊疗,2008,13(1):67-70.
-
5唐鹏,郭乔楠,姜军.肿瘤组织缺氧诱导VEGF表达的分子机制[J].现代生物医学进展,2007,7(3):443-444. 被引量：1
-
6唐鹏,郭乔楠,姜军.肿瘤组织缺氧诱导VEGF表达的分子机制[J].现代生物医学进展,2007,7(1):157-158. 被引量：2
-
7伊藤义彰,王静舒.脑微循环的正常状态和各种病理变化——不同于其他脏器的特征[J].日本医学介绍,2002,23(11):492-496. 被引量：5
-
8潘凌亚,金滢,黄惠芳,沈铿,吴鸣,郎景和.复发性卵巢癌治疗时机和策略的探讨[J].癌症,2003,22(11):1188-1192. 被引量：4
-
9黄晖婷,彭琪,夏平方,魏姗姗,李倩,余妙容.靶向骨髓微环境治疗急性白血病的研究进展[J].国际输血及血液学杂志,2016,39(2):139-142. 被引量：4
-
10郜丽,陈磊,苗书全,李欣,李忠照,崔艳,黄耀强.支气管扩张影像学分析与思考[J].世界最新医学信息文摘,2013,13(9):245-245.
